Kazım Uygun

6PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 28, 2026
EASIX Score as an Independent Prognostic Marker in De Novo Metastatic Pancreatic Cancer.

İlkay Çıtakkul, Yasemin Bakkal Temi, Zehra Aytin

|Feb 11, 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu

|Sep 19, 2025
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Gökhan Şahin, Esmanur Kaplan Tüzün, Halil G Güzel

|Jun 08, 2021
Perceptions and acceptance of telemedicine among medical oncologists before and during the COVID-19 pandemic in Turkey.

Elif Sahin, Umut Kefeli, Devrim Cabuk

|Nov 08, 2019
Gastrointestinal Involvement in a Patient with Chronic Lymphocytic Leukemia

Devrim Çabuk, Fatih Ballı, Yasin Yılmaz

Pageof 1